fda urges caution with clot buster

[Guest guest]

Subj: Fwd: FDA Urges Caution With Clot-Buster

Date: 1/30/99 1:13:13 AM CST

From: LifeSaveIn

BCC: LArmstr853

Re: Clot-Buster drug:

A small lesson in drug production and source, hence need to understand the

risk of introducing rider animal infections (micro-bacteria, viral and prion).

Essentially all hormone or cellular enzyme drugs are animal (including human

fetus, cadaver, or bacterial) derived. So we are subjecting the human patient

to the risk of infecting him with one animal disease while we are treating him

for his current animal blood, grease and bacteria derived disease! (In this

case: blocked arteries.)

Please get the clue exposed here!

The pharmaceuticals are produced from and because of our animal appetite.

So our " blood and horror " habits provide for their gold and silver treasure!

They provide, and profit! - you pay, partake and still lose!

Lesson here: Change habits, live (with clear arteries - no drug) and win!

TLRodgers

-----------------

Forwarded Message:

Subj: FDA Urges Caution With Clot-Buster

Date: 1/26/99 3:40:34 PM CST

From: AOL News

FDA Urges Caution With Clot-Buster

..c The Associated Press

WASHINGTON (AP) -- The Food and Drug Administration urged doctors to consider

prescribing alternative drugs to Abbott Laboratories' clot-buster Abbokinase,

saying it poses a potential risk of spreading infectious disease.

In a letter to doctors Monday, the FDA warned that Abbokinase, known

chemically as urokinase, should ``be reserved only for those situations where

a physician has considered the alternatives and has determined that the use of

Abbokinase is critical.''

Abbokinase is one of many drugs used to dissolve blood clots. It is made from

kidney cells taken from newborns who have died.

FDA inspectors halted shipments of Abbokinase in November after uncovering

``significant deviations'' from manufacturing rules that ensure drugs' purity

and safety.

The FDA said the kidney cells were taken from foreign newborns who were at

high risk of carrying infectious diseases, including hepatitis C, yet Abbott

didn't adequately test for infection. Also, the FDA said the cells were

handled in a way that could have allowed contamination.

The FDA has no evidence that Abbokinase actually was contaminated and is

letting shipments resume with Abbott's agreement to tighten manufacturing

safety.

Still, the agency used the incident to warn doctors to weigh the potential

risk of infection inherent to Abbokinase because it is made from human cells.

``We're just saying, consider the alternatives,'' said FDA's Dr. Feigal.

``It is a reminder that some of the other products are not human-sourced, so

they do have different risks.''

AP-NY-01-26-99 1639EST

Copyright 1998 The Associated Press. The information contained in the AP

news report may not be published, broadcast, rewritten or otherwise

distributed without prior written authority of The Associated Press.

To edit your profile, go to keyword aol://1722:NewsProfiles " >

NewsProfiles.

For all of today's news, go to keyword aol://1722:News " >News.